Project Abstract

Abstract
MicroRNAs (miRNAs) are small non-coding RNA molecules that play crucial roles in the post-transcriptional regulation of gene expression. Dysregulation of miRNAs has been implicated in various diseases, including cancer. In this study, we aimed to investigate the role of miRNAs in regulating gene expression in cancer cells, focusing on their potential as therapeutic targets. The research project involved a comprehensive literature review to understand the current knowledge of miRNA involvement in cancer development and progression. Ten key studies were analyzed to identify specific miRNAs that have been consistently associated with cancer and to elucidate their mechanisms of action in regulating gene expression. In the research methodology, we utilized various molecular biology techniques to investigate the expression levels of selected miRNAs in cancer cell lines. We designed experiments to assess the impact of manipulating these miRNAs on the expression of target genes involved in cancer pathways. Cell culture assays, quantitative PCR, and bioinformatics analysis were employed to characterize the regulatory effects of miRNAs on gene expression. The results of our study revealed significant dysregulation of specific miRNAs in cancer cells compared to normal cells. Through functional experiments, we demonstrated that modulating the expression of these miRNAs led to alterations in the expression of key genes involved in cancer progression, providing mechanistic insights into the regulatory role of miRNAs in cancer. The findings from this research contribute to the understanding of the molecular mechanisms underlying cancer development and highlight the potential of miRNAs as therapeutic targets for cancer treatment. The identification of specific miRNAs that play critical roles in regulating gene expression in cancer cells opens up new avenues for the development of novel miRNA-based therapies. In conclusion, this study offers valuable insights into the role of miRNAs in cancer pathogenesis and provides a foundation for further research in the field of miRNA-based cancer therapy. By elucidating the intricate regulatory networks mediated by miRNAs in cancer cells, this research paves the way for the development of targeted therapeutic strategies aimed at modulating gene expression to combat cancer progression.

Project Overview

The project aims to investigate the intricate role of microRNAs in the regulation of gene expression within cancer cells. MicroRNAs are small non-coding RNA molecules that play a crucial role in post-transcriptional gene regulation by binding to specific messenger RNA (mRNA) targets, thus influencing gene expression. In cancer, dysregulation of microRNAs has been implicated in various aspects of tumorigenesis, including cell proliferation, apoptosis, metastasis, and drug resistance. By focusing on the relationship between microRNAs and gene expression in cancer cells, this research seeks to unravel the underlying mechanisms driving cancer progression. The study will involve the identification and characterization of specific microRNAs that are dysregulated in different types of cancer cells. Through experimental techniques such as RNA sequencing, quantitative PCR, and functional assays, the project aims to elucidate how these dysregulated microRNAs impact the expression of target genes involved in cancer development and progression. Furthermore, the research will delve into the signaling pathways and biological processes influenced by dysregulated microRNAs in cancer cells. Understanding the functional consequences of altered microRNA expression on gene regulation can provide valuable insights into the molecular mechanisms driving oncogenesis. This knowledge may pave the way for the development of novel therapeutic strategies targeting microRNAs for cancer treatment. Overall, this project represents a comprehensive investigation into the role of microRNAs in regulating gene expression in cancer cells, with the ultimate goal of advancing our understanding of cancer biology and potentially identifying new therapeutic targets for combating this complex disease.